Literature DB >> 33711952

Statistical and bioinformatic analysis of hemimethylation patterns in non-small cell lung cancer.

Shuying Sun1, Austin Zane2, Carolyn Fulton3, Jasmine Philipoom4.   

Abstract

BACKGROUND: DNA methylation is an epigenetic event involving the addition of a methyl-group to a cytosine-guanine base pair (i.e., CpG site). It is associated with different cancers. Our research focuses on studying non-small cell lung cancer hemimethylation, which refers to methylation occurring on only one of the two DNA strands. Many studies often assume that methylation occurs on both DNA strands at a CpG site. However, recent publications show the existence of hemimethylation and its significant impact. Therefore, it is important to identify cancer hemimethylation patterns.
METHODS: In this paper, we use the Wilcoxon signed rank test to identify hemimethylated CpG sites based on publicly available non-small cell lung cancer methylation sequencing data. We then identify two types of hemimethylated CpG clusters, regular and polarity clusters, and genes with large numbers of hemimethylated sites. Highly hemimethylated genes are then studied for their biological interactions using available bioinformatics tools.
RESULTS: In this paper, we have conducted the first-ever investigation of hemimethylation in lung cancer. Our results show that hemimethylation does exist in lung cells either as singletons or clusters. Most clusters contain only two or three CpG sites. Polarity clusters are much shorter than regular clusters and appear less frequently. The majority of clusters found in tumor samples have no overlap with clusters found in normal samples, and vice versa. Several genes that are known to be associated with cancer are hemimethylated differently between the cancerous and normal samples. Furthermore, highly hemimethylated genes exhibit many different interactions with other genes that may be associated with cancer. Hemimethylation has diverse patterns and frequencies that are comparable between normal and tumorous cells. Therefore, hemimethylation may be related to both normal and tumor cell development.
CONCLUSIONS: Our research has identified CpG clusters and genes that are hemimethylated in normal and lung tumor samples. Due to the potential impact of hemimethylation on gene expression and cell function, these clusters and genes may be important to advance our understanding of the development and progression of non-small cell lung cancer.

Entities:  

Keywords:  Bioinformatics; Epigenetics; Hemimethylation; Lung Cancer; Methylation

Mesh:

Substances:

Year:  2021        PMID: 33711952      PMCID: PMC7953768          DOI: 10.1186/s12885-021-07990-7

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  58 in total

1.  Analysis of the frequency of GNAS codon 201 mutations in advanced colorectal cancer.

Authors:  S Idziaszczyk; C H Wilson; C G Smith; D J Adams; J P Cheadle
Journal:  Cancer Genet Cytogenet       Date:  2010-10-01

2.  Resolution of the DNA methylation state of single CpG dyads using in silico strand annealing and WGBS data.

Authors:  Chenhuan Xu; Victor G Corces
Journal:  Nat Protoc       Date:  2019-01       Impact factor: 13.491

Review 3.  Clinical implications of the deregulated TP73 isoforms expression in cancer.

Authors:  N Rodríguez; A Peláez; R Barderas; G Domínguez
Journal:  Clin Transl Oncol       Date:  2017-12-11       Impact factor: 3.405

4.  Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement.

Authors:  Toshihiko Imamura; Akira Morimoto; Mami Takanashi; Shigeyoshi Hibi; Tohru Sugimoto; Eiichi Ishii; Shinsaku Imashuku
Journal:  Br J Haematol       Date:  2002-10       Impact factor: 6.998

Review 5.  DNA hypomethylation in cancer cells.

Authors:  Melanie Ehrlich
Journal:  Epigenomics       Date:  2009-12       Impact factor: 4.778

6.  ConsensusPathDB: toward a more complete picture of cell biology.

Authors:  Atanas Kamburov; Konstantin Pentchev; Hanna Galicka; Christoph Wierling; Hans Lehrach; Ralf Herwig
Journal:  Nucleic Acids Res       Date:  2010-11-11       Impact factor: 16.971

7.  Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer.

Authors:  Liangliang Cai; Hua Bai; Jianchun Duan; Zhijie Wang; Shugeng Gao; Di Wang; Shuhang Wang; Jun Jiang; Jiefei Han; Yanhua Tian; Xue Zhang; Hao Ye; Minghui Li; Bingding Huang; Jie He; Jie Wang
Journal:  J Immunother Cancer       Date:  2019-07-26       Impact factor: 13.751

8.  Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer.

Authors:  Yin-Hsun Feng; Yu-Chu Su; Shuo-Fu Lin; Pey-Ru Lin; Chao-Liang Wu; Chao-Ling Tung; Chien-Feng Li; Gia-Shing Shieh; Ai-Li Shiau
Journal:  BMC Cancer       Date:  2019-08-09       Impact factor: 4.430

9.  Epigenetic regulation of NOTCH1 and NOTCH3 by KMT2A inhibits glioma proliferation.

Authors:  Yin-Cheng Huang; Sheng-Jia Lin; Hung-Yu Shih; Chung-Han Chou; Hsiao-Han Chu; Ching-Chi Chiu; Chiou-Hwa Yuh; Tu-Hsueh Yeh; Yi-Chuan Cheng
Journal:  Oncotarget       Date:  2017-06-27

10.  Hemimethylation of CpG dyads is characteristic of secondary DMRs associated with imprinted loci and correlates with 5-hydroxymethylcytosine at paternally methylated sequences.

Authors:  Julianna Nechin; Emma Tunstall; Naideline Raymond; Nicole Hamagami; Chris Pathmanabhan; Samantha Forestier; Tamara L Davis
Journal:  Epigenetics Chromatin       Date:  2019-10-17       Impact factor: 4.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.